GlassScriptPhysician profile
Erika E Morikawa
NPI 1346804473
$1,263.37
in general payments reported to CMS, 2019-2025
17 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $123 · 2024: $121 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $220.05 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $129.38 | 2025 | |
| Harmony Biosciences LLC | $123.06 | 2025 | |
| Janssen Pharmaceuticals, INC | $123.06 | 2023 | Xarelto |
| Shionogi INC | $120.72 | 2024 | Fetroja |
| Exact Sciences Corporation | $75.17 | 2025 | The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $74.78 | 2025 | Slynd |
| Evofem Biosciences, INC. | $73.64 | 2025 | Solosec, Phexx, Phexxi |
| Millicent US INC | $68.31 | 2025 | Femlyv, Intrarosa, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $61.52 | 2025 | |
| Organon LLC | $50.29 | 2025 | Nexplanon |
| Medtronic, INC. | $32.47 | 2025 | Truclear |
| Coopersurgical, INC. | $25.52 | 2025 | Paragard T 380a |
| Astellas Pharma US INC | $24.09 | 2025 | Veozah |
| Supernus Pharmaceuticals, INC. | $23.78 | 2025 | Qelbree |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $18.97 | 2025 | Myfembree |
| Shield Therapeutics INC | $18.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Morikawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.